Comparison of sirolimus-eluting, paclitaxel-eluting, and bare-metal stents in a patient with angina pectoris: histopathological autopsy findings of the third month

Cardiovasc Interv Ther. 2014 Oct;29(4):334-8. doi: 10.1007/s12928-013-0233-5. Epub 2013 Dec 10.

Abstract

A 67-year-old man with a more than 15-year-old history of hypertension, dyslipidemia, and glucose intolerance presented at our hospital with exertional angina. Coronary angiography showed considerable stenosis of 3 vessels. A diffuse calcified lesion in the left anterior descending coronary artery was pre-treated using rotational atherectomy followed by sirolimus-eluting stent (SES) implantation. A lesion in the proximal right coronary artery was treated by bare-metal stent (BMS) implantation, and the tandem lesion in the left circumflex artery was treated using paclitaxel-eluting stent (PES) implantation. All the procedures were performed within 1 month of the initial presentation and yielded good angiographic results. 3 months after the final stenting, the patient was re-admitted because of congestive heart failure (CHF). While recovering from CHF, he suddenly developed cardiopulmonary arrest and died during hospitalization. Autopsy examination of the coronary arteries showed that both drug-eluting stents (DESs: SES and PES) and the BMS had characteristic histopathological features. Inflammatory responses in the neointima were greater in both the DESs than in the BMS. SES and PES showed different inflammatory infiltration pattern or fibrin deposition status; these histopathological differences observed in the DES environments have implication to cause adverse clinical events such as late stent thrombosis or late catch-up phenomena.

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Aged
  • Angina Pectoris / therapy*
  • Angioplasty, Balloon, Coronary / instrumentation
  • Autopsy
  • Coronary Angiography
  • Coronary Vessels / pathology
  • Drug-Eluting Stents*
  • Fatal Outcome
  • Humans
  • Male
  • Paclitaxel / administration & dosage*
  • Postoperative Complications
  • Sirolimus / administration & dosage*
  • Thrombosis / etiology
  • Treatment Outcome

Substances

  • Paclitaxel
  • Sirolimus